Global Fund Grant Proposal

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Planning in line with the Stop TB Strategy and the Global Plan to Stop TB, Dr Win Maung Programme Manager National Tuberculosis Programme Ministry.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Technical Advisory Group meeting, WHO/WPRO
1 TB service and Health insurance Extending TB benefit package to help mitigate economic burden of TB patients, Cambodia contex TAG-NTP manager Meeting.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
China TB Control Progress Report The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
TUBERCULOSIS CONTROL Experience of Guyana Dr Jeetendra Mohanlall
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
“World TB day and TB in Mongolia”
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Group discussion Urban Slums Rapporteur: Joseph K Sitienei Facilitators: B. Squire, I. Onozaki.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Experiences in Tanzania: Community Based Efforts to Support HIV/TB Integration Jackson Mugyabuso Dr. Charlotte Colvin PATH 25 July 2012.
Screening for TB among risk groups in Cambodia Dr. Mao Tan Eang, NTP Director National Center for TB and Leprosy Control, Cambodia TAG Meeting, 9-12 December.
Tuberculosis control in Suriname Situational analysis.
Group 1 Presentation: HIV Testing in TB Patients and ART Provision.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
SUMMARY OF IMPLEMENTATION RESULTS TB Project Round 1 Strengthening access to WHO Standard TB Care and Services for Marginalized Population, Cross-border.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
Tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Strengthening TB and HIV&AIDS Responses in East Central Uganda Strengthening Laboratory TB diagnostic capacity of peripheral laboratories in East Central.
Outline The Global Fund Strategy emphasizes the Key Populations
NDPHS PHC EG Draft Workshop report, Attachment 3
Current harm reduction program at outreach
Increased access to quality TB drugs
Tailored Review Proposal for Tuberculosis
Country Progress Report Cambodia
Zaw Win, Tin Aung, Sun Tun Population Services International/ Myanmar
TB Control in PHC network and Partners Coordination in Cambodia
Progress in Implementation of TB/HIV Collaborative activities
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
The role of the community in TB control
3rd Global WG on TB/HIV, Montreux, 4-6 June, 2003
TB epidemiological situation in Kyrgyzstan
5th DEWG meeting Conclusions
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
5th edition NTP MANUAL OF PROCEDURES Chapter 1: Introduction
Presentation transcript:

Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriela Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh

Tuberculosis Burden 22 High Burden TB countries account for 80% of the world's TB cases- Cambodia is one of those high burden countries as identified by the WHO. Cambodia leads the region in incidence, prevalence, and deaths due to TB 1993 Reestablishment of the national DOTS program History of GF grants Round 2, 2004: Tuberculosis Grant: Decentralization Round 5, 2006: Tuberculosis Grant: Scaling up Rural TB & TB/HIV Services Round 7, 2009: Tuberculosis Grant: MDRTB, TB/HIV, and Lab Services

Tuberculosis Incidence Incidence: 62,000 new cases 437 per 100,000 population

Tuberculosis Deaths TB Deaths: 8,600 deaths 61 per 100,000 population

Tuberculosis Case Detection

Provincial Map 100% DOTS Coverage Rate DOTS availability (2007): 41 health operational districts (of 77 total) 461 Health Centers (of 966 total) 80% of the population is rural 21% of poorest 1/5 of the population travel 5km+ to reach a health center.

Strength: Treatment Success Unknown Threat: MDR-TB Treatment, MDR-TB, and HIV Strength: Treatment Success Unknown Threat: MDR-TB The HIV/TB Disconnect Reach of HIV services does not extend as far as the decentralized DOTS program The main barrier relates to limited access to culture for diagnosing sputum smear-negative disease 70-100% of all newly diagnosed HIV-infected persons screened for TB, but only 14-83% of TB patients were tested for HIV. The rate of active disease found upon screening ranged from 9% to 26%.

Inputs and Activities Promoting Decentralization -Expansion of basic services rurally by expanding DOTS to all health centers -Operational research funding (Nate) Improving Case detection (Xiao) -Implement active case finding -Private sector engagement -Mobile microscopy service pilot Diagnostics (Nate) -Expand access to diagnostics rurally -Establish Universal DST access means Healthcare Worker Training (Becca) -2.3 doctors and 7.9 nurses per 10,000 -Training low skilled health workers DOTS Structural Support -Funding security -Streamlining coordination within decentralized system Drugs Procurement (Paa) -59,784 people require treatment -Secure 1st line drug supply chains -Stockpile 2nd line drugs HIV/TB Service Expansion (case det.) -Coordination of TB and HIV scale up by health center catchment Vulnerable Populations (part of case det) -Targeting of impoverished, slum areas, and ethnic minorities

Some Outputs Promoting Decentralization DOTS Structural Support -Improved access to DOTS rurally Improving Case detection -Achieve case detection above 75% -Increase % completing treatment Diagnostics -Characterize MDR-TB burden -Streamline diagnosis and treatment Healthcare Worker Training -Task shifting without internal brain drain DOTS Structural Support -Coordinated data collection -Sustainability Drugs Procurement -Avoid stockouts -Access to MDR/XDR-TB Treatment HIV/TB Service Expansion -Integration of services -Improved health metric outcomes Vulnerable Populations -Reducing TB clusters and health disparities

End

Random Slides

Case Finding Gaps

Tuberculosis Tuberculosis Treatment, Care and Support   Treatment, Care and Support # of treatment units implementing DOTS # of estimated new smear-positive TB cases detected under DOTS # of smear-positive TB cases registered under DOTS successfully treated* # of persons completing DOTS+ treatment for MDR-TB*

What the program does with the inputs to fulfill its mission IMPACT Resources dedicated to or consumed by the program What the program does with the inputs to fulfill its mission Direct products of program activities Political commitment Allocates the highest percentage of government’s budget on health (16%). Still insufficient: 2002 was $2.7 per capita and about $5.8 in 2009. Below minimal care package of $12 per person Goal attainment

Brief History 1863 - Cambodia becomes a protectorate of France. French colonial rule lasts for 90 years. 1953 - Cambodia wins its independence from France. 1975 - Khmer Rouge led by Pol Pot occupy Phnom Penh. Year Zero starts. The total death toll during the next three years is estimated to be at least 1.7 million. 1979 The Vietnamese take Phnom Penh. Pol Pot and Khmer Rouge forces flee to the border region with Thailand. 1993 The MoH reestablishes its long nascent national TB program

Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriela Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh

Sources of Loss in TB Gap Analysis GF Goals Potential Case Health Seeking Public Health System Diagnosis DOTS Treatment Sources of Loss in TB GF Goals 1.)  Case Detection to 80% 2.) Maintain Treatment Success Rate 3.)  Mortality Rate High Risk, Barriers to care Diagnostics DOTS Workers Health Staff Drug Supplies Private Sector Tracking Gap Analysis 92% treatment success 65% Case Detection

Cambodia Tuberculosis Funding Major Impact Categories 1. Improve Case Finding 2. Decentralization 3. System Strengthening Total 5 Year Budget: $81,535,403 Year 1 Budget: $24,311,481

Public-Private Management Increase Case Detection Active Case Finding Public-Private Management Community Contact Tracing Case finding Campaigns 40 sites TB screening at 55 ART sites HIV screening at all TB centers Costs: $30,000/ Screening Van x 30 S160/ case found in campaigns $400/ TB case diagnosed at HIV clinics Expand PPM in 2 more districts Train private providers & pharmacists on Nat’l Guidelines DOTS in select private clinics Referral database Details: $800/ mo. National PPM Director $500/ mo./ PPM NGO staff

Decentralization C-DOTS 228 Microscopy centers 5 Culture labs upgrades Diagnostics C-DOTS 228 Microscopy centers 5 Culture labs upgrades Digital X-Ray Pilot Diagnostic Staff Details: $130/ microscope x 1000 $1500/staff/yr. x 456 $40,000/ x-ray machine x 10 DOTS provision at 1051 HCs Support of 6000+ treatment cases Trainings of 9,800 DOTS watchers Community Advocacy activities Details: DOTS trainings in all 77 ODs $130/ case covered by DOTS $32/ case related to M & E activity Monthly supervisory visits to DOTS sites

TB System Strengthening Drugs Health Staffing Health Info System HIS Training HIS staff Compliance with Nat’l Reporting guidelines Details: 1000 staff trainings/yr 4000 refreshers/yr 200,000 1st Line 90,000 2nd Line 100,000 BCG vaccine 30,000 Vitamin B Details: $5/ 1st-line treatment $50/ 2nd line treatment 0.10/ Vit. B dose $2/ BCG Vaccine Public Salary Top Up Rural Staff Incentive Details: $4800/yr/doctor x 77 ODs $2400/yr/nurse x1051 HCs $50/yr./rural staff stipend

Thanks!

Objective Emphasis Improve Case Detection Active Case Finding Private-Public Mix Decentralization Improve diagnostic capacity Expand C-DOTS TB System Strengthening Drug Supplies Adequate Staffing Levels Health Info System